Simplified hierarchical linear models for the evaluation of surrogate endpoints
From MaRDI portal
Publication:4432903
Cited in
(13)- Flexible surrogate marker evaluation from several randomized clinical trials with continuous endpoints, using R and SAS
- Center-within-trial versus trial-level evaluation of surrogate endpoints
- Simplified modeling strategies for surrogate validation with multivariate failure-time data
- The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials
- Statistical evaluation of surrogate endpoints with examples from cancer clinical trials
- Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach
- On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpoints
- Unbalanced cluster sizes and rates of convergence in mixed-effects models for clustered data
- Exploring the relationship between the causal-inference and meta-analytic paradigms for the evaluation of surrogate endpoints
- Differences in surrogate threshold effect estimates between original and simplified correlation-based validation approaches
- An information-theoretic approach to surrogate-marker evaluation with failure time endpoints
- Choice of units of analysis and modeling strategies in multilevel hierarchical models
- Using earlier measures in a longitudinal sequence as a potential surrogate for a later one
This page was built for publication: Simplified hierarchical linear models for the evaluation of surrogate endpoints
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4432903)